Europe - BIT:1ELX - US5184391044 - Common Stock
The current stock price of 1ELX.MI is 73.6 EUR. In the past month the price increased by 26.46%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| OR.PA | L'OREAL | 28.08 | 191.11B | ||
| LOR.DE | L'OREAL | 27.99 | 190.50B | ||
| BEI.DE | BEIERSDORF AG | 23.45 | 22.47B | ||
| ITP.PA | INTERPARFUMS SA | 15.67 | 2.30B | ||
| ICOS.MI | INTERCOS SPA | 23.33 | 1.10B | ||
| ONTEX.BR | ONTEX GROUP NV | 52.83 | 522.10M | ||
| PHN.MI | PHARMANUTRA SPA | 20.65 | 489.81M | ||
| ENV.MI | ENERVIT | 16.56 | 73.69M | ||
| JBOG.PA | JACQUES BOGART | N/A | 68.09M |
The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. The company is headquartered in New York City, New York and currently employs 57,000 full-time employees. Its product categories include skin care, makeup, fragrance, hair care and others. Its products are sold in approximately 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD. The company is a licensee for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include lipsticks, lip glosses, mascaras, foundations and others.
ESTEE LAUDER COMPANIES-CL A
767 Fifth Avenue
New York City NEW YORK US
Employees: 57000
Phone: 12125724200
The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. The company is headquartered in New York City, New York and currently employs 57,000 full-time employees. Its product categories include skin care, makeup, fragrance, hair care and others. Its products are sold in approximately 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD. The company is a licensee for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include lipsticks, lip glosses, mascaras, foundations and others.
The current stock price of 1ELX.MI is 73.6 EUR. The price decreased by -10.02% in the last trading session.
ESTEE LAUDER COMPANIES-CL A (1ELX.MI) has a dividend yield of 1.59%. The yearly dividend amount is currently 1.49.
1ELX.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
1ELX.MI stock is listed on the Euronext Milan exchange.
The Revenue of ESTEE LAUDER COMPANIES-CL A (1ELX.MI) is expected to grow by 3.87% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ESTEE LAUDER COMPANIES-CL A (1ELX.MI) has a market capitalization of 26.52B EUR. This makes 1ELX.MI a Large Cap stock.
ChartMill assigns a technical rating of 4 / 10 to 1ELX.MI.
ChartMill assigns a fundamental rating of 3 / 10 to 1ELX.MI. 1ELX.MI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months 1ELX.MI reported a non-GAAP Earnings per Share(EPS) of 1.45. The EPS decreased by -36.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.81% | ||
| ROE | -23.91% | ||
| Debt/Equity | 1.88 |
36 analysts have analysed 1ELX.MI and the average price target is 82.78 EUR. This implies a price increase of 12.47% is expected in the next year compared to the current price of 73.6.
For the next year, analysts expect an EPS growth of 46.73% and a revenue growth 3.87% for 1ELX.MI